Home › Funds › CVS HEALTH Corp › IGLB
CVS HEALTH Corp position in IGLB
ISHARES TR
CVS HEALTH Corp reported holding 230,000 shares of IGLB (ISHARES TR) in its Q3 2026 13F filing — a position valued at US$10.5M, representing 2.45% of its reported portfolio and ranking #11 among its reported holdings. CVS HEALTH Corp has disclosed IGLB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CVS HEALTH Corp's IGLB position evolved
CVS HEALTH Corp first disclosed a stake in IGLB in Q1 2026 at 100,000 shares (US$5.0M). The position peaked in Q3 2026 at 230,000 shares, worth US$10.5M. Across 3 filings, CVS HEALTH Corp increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 230,000 shares valued at US$10.5M — an increase of 55,000 shares quarter over quarter.. Notable position changes include a 75% increase in Q2 2026 (shares fell 9% over the following quarter), a 31% increase in Q3 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 100.00K | $4.96M | New |
| Q2 2026 | 175.00K | $8.76M | Add |
| Q3 2026 | 230.00K | $10.50M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IGLB and 13F data
IGLB (ISHARES TR) is a company whose sector is not yet classified in our data. 27 other funds we track also report a position in IGLB — the largest reported positions include PRUDENTIAL PLC (US$152.8M), RiverFront Investment Group, LLC (US$90.1M), ALLSTATE CORP (US$76.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IGLB
- PRUDENTIAL PLC 3.35M sh · $152.79M · Q3 2026
- RiverFront Investment Group, LLC 1.97M sh · $90.08M · Q3 2026
- ALLSTATE CORP 1.52M sh · $76.14M · Q2 2026
- ALLIANZ SE 1.62M sh · $74.06M · Q3 2026
- CLIFTONLARSONALLEN WEALTH ADVISORS, LLC 1.00M sh · $45.84M · Q3 2026
- Gallagher Fiduciary Advisors, LLC 833.03K sh · $41.68M · Q2 2026
- NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC 619.38K sh · $28.28M · Q3 2026
- Fund Evaluation Group, LLC 508.81K sh · $23.23M · Q3 2026
- Klaas Financial Asset Advisors, LLC 488.14K sh · $22.29M · Q3 2026
- NYL Investors LLC 412.44K sh · $18.83M · Q3 2026
- Insight Wealth Strategies, LLC 384.50K sh · $17.56M · Q3 2026
More on CVS HEALTH Corp
FAQ
How long has CVS HEALTH Corp held IGLB?
CVS HEALTH Corp has disclosed IGLB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is CVS HEALTH Corp's current position in IGLB?
As of Q3 2026, CVS HEALTH Corp holds 230.00K shares of IGLB (ISHARES TR), valued at $10.50M, representing 2.45% of its reported portfolio and ranking #11.
Has CVS HEALTH Corp been buying or selling IGLB?
In the latest 13F filing (Q3 2026), CVS HEALTH Corp increased its position in IGLB. The position peaked in Q3 2026 at 230.00K shares.
Which other funds hold IGLB?
Other major institutional holders of IGLB include PRUDENTIAL PLC, RiverFront Investment Group, LLC, ALLSTATE CORP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.